Skip to content
akaturk Academic measurement

Article detail · 2021

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

Journal

LANCET NEUROLOGY

ISSN 1474-4422

The ISSN points to another catalog journal; the name is from the YÖKSİS record.

YÖKSİS OpenAlex SJR Q1 JCR Q1 Citations 161 Top 10% Percentile 98.2% FWCI 7.11
Year
2021
Type
article

Data source split

  • YÖKSİS YÖKSİS article record
  • YÖKSİS venue LANCET NEUROLOGY
  • Catalog match (ISSN) The Lancet Neurology
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

Abstract not compiled yet; it will appear after the DergiPark / OpenAlex queue runs.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

161 citations

OpenAlex cited_by_count (cache / database)

2 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy 2025 Citations 37 · OpenAlex
  2. Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy 2025 Citations 35 · OpenAlex

Authors

  1. EMRE ALTINKURT
  2. SACİT KARAMÜRSEL KOÇ ÜNİVERSİTESİ